<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A family was investigated for <z:chebi fb="5" ids="28304">heparin</z:chebi> co-<z:e sem="disease" ids="C0020640" disease_type="Disease or Syndrome" abbrv="">factor II deficiency</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Three of the five members examined had had <z:mp ids='MP_0005048'>thrombosis</z:mp> and their levels of <z:chebi fb="5" ids="28304">heparin</z:chebi> co-factor II were reduced to 50% </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> five members had antithrombin III levels within the <z:mpath ids='MPATH_458'>normal</z:mpath> range </plain></SENT>
<SENT sid="3" pm="."><plain>Analysis on crossed immunoelectrophoresis showed no qualitative abnormality of patient <z:chebi fb="5" ids="28304">heparin</z:chebi> co-factor II antigen </plain></SENT>
<SENT sid="4" pm="."><plain>Since <z:chebi fb="5" ids="28304">heparin</z:chebi> co-factor II activity and concentration were reduced to the same extent, the deficiency was due to reduced protein synthesis </plain></SENT>
</text></document>